Process for preparing 17-methylalkane compound

A novel method using a 1-halo-7-methyltricosane compound addresses the industrial viability issues of existing 17-methylalkane production by enabling high-yield, environmentally friendly production through distillation purification and coupling reactions, suitable for industrial scale-up.

JP2024160423AActive Publication Date: 2024-11-14SHIN ETSU CHEMICAL CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023075367
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-01
Publication Date
2024-11-14
Estimated Expiration
2043-05-01

AI Technical Summary

Technical Problem

Existing methods for producing 17-methylpentatriacontane and 17-methylheptatriacontane are not industrially viable due to the use of toxic solvents like benzene, flammable materials like palladium carbon, and the difficulty in purifying intermediates by distillation, leading to low yields and low productivity.

Method used

A novel method using a 1-halo-7-methyltricosane compound as a synthetic intermediate, which can be purified by distillation and produced in high yield through coupling reactions with alkyl electrophiles, allowing for efficient production of 17-methylalkane compounds.

Benefits of technology

The method enables the production of 17-methylalkane compounds with high yield and low environmental impact, suitable for industrial scale-up, by ensuring sufficient boiling point differences for easy purification and using easily handled liquid raw materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024160423000001
    Figure 2024160423000001
  • Figure 2024160423000002
    Figure 2024160423000002
  • Figure 2024160423000003
    Figure 2024160423000003
Patent Text Reader

Abstract

To provide: a novel compound as a synthetic intermediate for efficiently preparing 17-methylalkane compounds; a process for preparing the same; and a process for preparing 17-methylalkane compounds.SOLUTION: A preparation process includes the step of a coupling reaction of a compound represented by the formula 5 (5: M2=MgCl) in the figure with 1-bromo-5-chloropentane to obtain a 17-methylalkane compound represented by the formula 1 (1: X1=Cl) in the figure.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing a 17-methylalkane compound. More specifically, the present invention relates to a method for producing a 17-methylalkane compound by using the Argentine ant ( Linepithema humile This invention relates to a method for producing 17-methylpentatriacontane and 17-methylheptatriacontane, which are nestmate recognition pheromones of the moth, Moth. [Background technology]

[0002] Argentine ant ( Linepithema humile ) have invaded countries around the world, forming supercolonies to drive out native ants, and thus exerting a great influence on ecosystems. In addition, Argentine ants obtain honeydew from agricultural pests aphids and scale insects, forming a symbiotic relationship with these pests in exchange for protecting these pests from natural enemies, so in areas with high Argentine ant densities, biological control using natural enemies is often ineffective. Furthermore, since they invade human homes through small gaps, they also have the aspect of being a sanitary pest. Until now, Argentine ants have been controlled by spraying insecticides, but this type of conventional insecticide spraying is not only ineffective against Argentine ants, but is also undesirable from an environmental perspective. For this reason, biological control methods that minimize the use of insecticides have been studied, and among these, control using nestmate recognition pheromones is expected to be one of the control methods (Non-Patent Documents 1 and 2 below).

[0003] Argentine ant ( Linepithema humileAs nestmate recognition pheromones of the mosquito, various compounds such as 15-methylpentatriacontane, 17-methylpentatriacontane, 5,13,17-trimethyltritriacontane, 5,13,17-trimethylpentatriacontane, and 5,13,17-trimethylheptatriacontane are known. Among them, it has been revealed that 5,13,17-trimethylalkane compounds such as 5,13,17-trimethyltritriacontane, 5,13,17-trimethylpentatriacontane, and 5,13,17-trimethylheptatriacontane, and 17-methylalkane compounds such as 17-methylpentatriacontane and 17-methylheptatriacontane are particularly active (Non-Patent Documents 1, 2, and 3 below). Of these, the following description will focus on 17-methylalkane compounds.

[0004] As a method for synthesizing 17-methylpentatriacontane, which is a 17-methylalkane compound, a method for producing it in a yield of 37.32% through a total of three steps has been reported (see Non-Patent Document 2 below). For example, 2-octadecanone is reacted with octadecylmagnesium bromide to synthesize 17-methyl-17-pentatriacontanol (first step), and the obtained 17-methyl-17-pentatriacontanol is heated to 1000° C. with an acid catalyst. p In the presence of -toluenesulfonic acid, this is subjected to a dehydration reaction in benzene to synthesize 17-methylenepentatriacontane (second step). Subsequently, the obtained 17-methylenepentatriacontane is subjected to a hydrogenation reaction in diethyl ether in the presence of palladium on carbon (Pd / C) (third step) to produce the above-mentioned 17-methylpentatriacontane (Non-Patent Document 2).

[0005] As a method for synthesizing 17-methylheptatriacontane, a 17-methylalkane compound, a method for producing it in a yield of 73.63% through a total of three steps has been reported (Non-Patent Document 2). For example, 2-octadecanone is reacted with eicosylmagnesium bromide to synthesize 17-methyl-17-heptatriacontanol (first step), and the obtained 17-methyl-17-heptatriacontanol is reacted with an acid catalyst p In the presence of -toluenesulfonic acid, this is subjected to a dehydration reaction in benzene to synthesize 17-methyleneheptatriacontane (second step). Subsequently, the obtained 17-methyleneheptatriacontane is subjected to a hydrogenation reaction in diethyl ether in the presence of palladium on carbon (Pd / C) (third step) to produce the above-mentioned 17-methylheptatriacontane. [Prior art documents] [Non-patent literature]

[0006] [Non-Patent Document 1] Neil D Tsutsui et al.,BMC Biology,2009,7,71. [Non-Patent Document 2] Neil D Tsutsui et al.,J.Chem.Ecol.,2010,36,751-758. [Non-Patent Document 3] E. Sunamura et al., Insectes Sociaux, 2009, 56, 143-147. [Non-Patent Document 4] Dennis H. Burns et al.,J. Am. Chem. Soc.,1997,119,2125-2133. Summary of the Invention [Problem to be solved by the invention]

[0007] However, in both of the methods for producing 17-methylpentatriacontane and 17-methylheptatriacontane in Non-Patent Document 2, a large amount of benzene, which is highly toxic to the human body, is used as a solvent, making them unsuitable for industrial use. Furthermore, flammable palladium carbon is used in a diethyl ether solvent, which is a special flammable material, making industrialization difficult. Furthermore, in the first step, as stated by the authors of Non-Patent Document 2, a hydrocarbon that is a homo-coupling product of a Grignard reagent is produced as a by-product. That is, in the reaction of reacting 2-octadecanone with octadecyl magnesium bromide, hexatriacontane is produced, and in the reaction of reacting 2-octadecanone with eicosyl magnesium bromide, tetracontane is produced. At this time, hexatriacontane (molecular weight: 506.99) has a molecular weight close to that of the target compound 17-methyl-17-pentatriacontanol (molecular weight: 522.97) and has a similar boiling point, making it difficult to purify by distillation. In addition, tetracontane (molecular weight: 563.08) is difficult to purify by distillation because it has a molecular weight and boiling point close to that of the target compound, 17-methyl-17-heptatriacontanol (molecular weight: 551.03). Therefore, in the first step, the authors perform purification by column chromatography instead of purification by distillation, and therefore purification by column chromatography is essential in this production method. Purification by column chromatography is difficult to carry out on an industrial scale (over 100 kg), and is therefore not suitable for industrial production.

[0008] In addition, 2-octadecanone used as a raw material is difficult to obtain industrially (more than 100 kg), so it must be synthesized separately, and since it is a solid at room temperature (25°C), it is troublesome to charge the solid into a reactor, while it is necessary to add a large amount of solvent or heat it to make it into a solution when charging it into a reactor as a solution, which results in low productivity and requires special equipment, making it unsuitable for industrial production. Furthermore, the Grignard reagent used in the first step is thought to be prepared from the corresponding bromoalkane and magnesium, but the corresponding bromoalkanes, 1-bromooctadecane and 1-bromoicosane, are both solids. However, these bromoalkanes, 1-bromooctadecane and 1-bromoicosane, need to be reacted with magnesium as a solution when preparing the Grignard reagent, so a large amount of solvent is required to make it into a solution, and therefore the productivity is low and it is unsuitable for industrial production. In addition, although the method for producing 17-methylpentatriacontane is similar to that for producing 17-methylpentatriacontane, the yield of 17-methylpentatriacontane is extremely low at 37.32% in all three steps. Therefore, it is difficult to industrially produce a 17-methylalkane compound with a high yield by the production method of Non-Patent Document 2.

[0009] The present invention has been made in view of the above circumstances, and aims to provide a novel compound that is a synthetic intermediate for efficiently producing 17-methylalkane compounds including 17-methylpentatriacontane and 17-methylheptatriacontane. Another aim of the present invention is to provide a method for producing the novel compound, and a method for producing 17-methylalkane compounds including 17-methylpentatriacontane and 17-methylheptatriacontane from the novel compound. [Means for solving the problem]

[0010] The present inventors have conducted intensive studies to solve the above problems, and have found that the 1-halo-7-methyltricosane compound according to the present invention is a novel compound. The 1-halo-7-methyltricosane compound can be produced inexpensively and in large quantities, and can be purified by distillation alone. The present inventors have also found that the 1-halo-7-methyltricosane compound efficiently produces 17-methylalkane compounds, including 17-methylpentatriacontane and 17-methylheptatriacontane. The production method can be produced in high yields by coupling reaction between a 7-methyltricosyl nucleophile, which can be easily prepared from the 1-halo-7-methyltricosane compound, and an alkyl electrophile, which is inexpensive and industrially available. The production method has also been found to be economical and industrially feasible for producing 17-methylpentatriacontane and 17-methylheptatriacontane.

[0011] According to a first aspect of the present invention, there is provided a compound represented by the following general formula (1): [ka] (In the formula, X 1 represents a halogen atom.) The present invention provides a 1-halo-7-methyltricosane compound represented by the formula:

[0012] According to a second aspect of the present invention, the 1-halo-7-methyltricosane compound (1) is represented by the following general formula (2): [ka] (In the formula, M 1 Li, MgZ 1 , CuZ 1 Or CuLiZ 1 represents Z 1 is halogen represents an atom or a 7-methyltricosyl group. Then, the 7-methyltricosyl nucleophile (2) is converted into a 7-methyltricosyl nucleophile represented by the following general formula (3): [ka] (In the formula, X 2 is a halogen atom or p -toluenesulfonyloxy group, and n is 11 to 13. By a coupling reaction with an alkyl electrophilic reagent represented by the following general formula (4): [ka] (In the formula, n is as defined above.) A process for obtaining a 17-methylalkane compound represented by the formula: The present invention provides a method for producing the 17-methylalkane compound (4), comprising at least the steps of:

[0013] According to a third aspect of the present invention, The following general formula (5): [ka] (In the formula, M 2 Li, MgZ 2 , CuZ 2 Or CuLiZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. and a 2-methyloctadecyl nucleophile represented by the following general formula (6): [ka] (In the formula, X 3 and X 4 represent halogen atoms which may be the same or different. and obtaining the 1-halo-7-methyltricosane compound (1) by a coupling reaction with a 1,5-dihalopentane compound represented by the following formula: The method for producing the 17-methylalkane compound (4) further comprises the steps of: (a) obtaining the 1-halo-7-methyltricosane compound (1) and (b) purifying the 1-halo-7-methyltricosane compound (1), and the purification step may be carried out by distillation alone.

[0014] According to a fourth aspect of the present invention, The following general formula (5): [ka] (In the formula, M 2 Li, MgZ 2 , CuZ 2 Or CuLiZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. and a 2-methyloctadecyl nucleophile represented by the following general formula (6): [ka] (In the formula, X 3 and X 4 represent halogen atoms which may be the same or different. and obtaining the 1-halo-7-methyltricosane compound (1) by a coupling reaction with a 1,5-dihalopentane compound represented by the following formula: The present invention provides a method for producing a 1-halo-7-methyltricosane compound (1), comprising the steps of: The method may further include a purification step of purifying the 1-halo-7-methyltricosane compound (1) after the step of obtaining the 1-halo-7-methyltricosane compound (1), and the purification step may be carried out only by distillation.

[0015] According to a fifth aspect of the present invention, The following general formula (5): [ka] (In the formula, M 2 Li, MgZ 2 , CuZ 2 Or CuLiZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. and a 2-methyloctadecyl nucleophile represented by the following general formula (6): [ka] (In the formula, X 3 and X 4 represent halogen atoms which may be the same or different. By a coupling reaction with a 1,5-dihalopentane compound represented by the following general formula (1): [ka] (In the formula, X 1 represents a halogen atom.) A process for obtaining a 1-halo-7-methyltricosane compound (1) represented by the formula: The present invention provides a method for producing the 1-halo-7-methyltricosane compound (1), comprising the steps of: The method may further include a purification step of purifying the 1-halo-7-methyltricosane compound (1) after the step of obtaining the 1-halo-7-methyltricosane compound (1), and the purification step may be carried out only by distillation. Effect of the Invention

[0016] According to the present invention, 17-methylalkane compounds including 17-methylpentatriacontane and 17-methylheptatriacontane, which are the target compounds, can be produced in high yields, economically, and efficiently with little environmental impact. In addition, according to the present invention, a sufficient boiling point difference can be obtained between the by-products produced in each step and the target compounds, so that purification by distillation suitable for scale-up is possible. Furthermore, according to the present invention, all of the raw materials and intermediates are liquid, so that they are easy to handle, and it is possible to achieve a reduction in environmental impact and a significant improvement in productivity. In addition, according to the present invention, a novel synthetic intermediate useful for producing the 17-methylalkane compounds can be provided. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0017] The present invention relates to a 1-halo-7-methyltricosane compound (1) represented by the following general formula (1) and a method for producing the same. (i) The above 1-halo-7-methyltricosane compound (1) will be explained below. [ka]

[0018] X in the above general formula (1) 1 represents a halogen atom. Halogen atom X 1 Specific examples of the alkyl group include a chlorine atom, a bromine atom, and an iodine atom. From the viewpoint of melting point or solvent solubility, a chlorine atom and a bromine atom are preferred, and a chlorine atom is particularly preferred.

[0019] Specific examples of the 1-halo-7-methyltricosane compound (1) include 1-chloro-7-methyltricosane, 1-bromo-7-methyltricosane, and 1-iodo-7-methyltricosane. As the 1-halo-7-methyltricosane compound (1), from the viewpoint of melting point or solvent solubility, 1-chloro-7-methyltricosane and 1-bromo-7-methyltricosane are preferred, and 1-chloro-7-methyltricosane is particularly preferred.

[0020] (ii) The method for producing the above 1-halo-7-methyltricosane compound (1) will now be described. For example, the 1-halo-7-methyltricosane compound (1) can be prepared by a coupling reaction between a 2-methyloctadecyl nucleophile represented by the following general formula (5) and a 1,5-dihalopentane compound represented by the following general formula (6), as shown in the following chemical reaction formula.

[0021] [ka]

[0022] (iii) The above 2-methyloctadecyl nucleophile (5) is explained below. M in the above general formula (5) 2 Li, MgZ 2 , CuZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. Halogen atom Z 2 Specific examples of the atom include a chlorine atom, a bromine atom, and an iodine atom.

[0023] Specific examples of the 2-methyloctadecyl nucleophilic reagent (5) include 2-methyloctadecyllithium; 2-methyloctadecylmagnesium halide reagents (Grignard reagents) such as 2-methyloctadecylmagnesium chloride, 2-methyloctadecylmagnesium bromide, and 2-methyloctadecylmagnesium iodide; bis[2-methyloctadecyl]cuprate; and Gilman reagents such as lithium bis[2-methyloctadecyl]cuprate. From the viewpoint of ease of preparation (versatility), the 2-methyloctadecylmagnesium halide reagent is preferred. The 2-methyloctadecyl nucleophilic reagent (5) may be used alone or in combination of two or more, as necessary. The 2-methyloctadecyl nucleophilic reagent (5) can be prepared, for example, by the production method described below.

[0024] (iv) Next, the above 1,5-dihalopentane compound (6) will be explained below. X in the above general formula (6) 3 and X 4 represent halogen atoms which may be the same or different. 3 and X 4 Specific examples of the atom include a chlorine atom, a bromine atom, and an iodine atom. X 3 and X 4 Examples of the combinations include a chlorine atom and a chlorine atom, a bromine atom and a chlorine atom, a chlorine atom and an iodine atom, a bromine atom and a bromine atom, a bromine atom and an iodine atom, and an iodine atom and an iodine atom. Specific examples of the 1,5-dihalopentane compound (6) include 1,5-dichloropentane, 1,5-dibromopentane, 1,5-diiodopentane, 1-bromo-5-chloropentane, 1-chloro-5-iodopentane, and 1-bromo-5-iodopentane, and from the viewpoint of yield, 1-bromo-5-chloropentane, 1-chloro-5-iodopentane, and 1-bromo-5-iodopentane are preferred. The 1,5-dihalopentane compound (6) may be used alone or in combination with two or more compounds as required. The 1,5-dihalopentane compound (6) may be a commercially available compound or may be independently synthesized.

[0025] The 1,5-dihalopentane compound (6) can be synthesized, for example, by halogenating 1,5-pentanediol.

[0026] (v) Next, the coupling reaction of the 2-methyloctadecyl nucleophile (5) with the 1,5-dihalopentane compound (6) will be described below. In the coupling reaction, the amount of the 2-methyloctadecyl nucleophilic reagent (5) used is preferably 0.8 to 1.4 moles per mole of the 1,5-dihalopentane compound (6) from the viewpoint of economic efficiency.

[0027] The coupling reaction may be carried out in the presence of a solvent, if necessary. Examples of the solvent include common solvents, such as ether solvents, such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbon solvents, such as hexane, heptane, benzene, toluene, xylene, and cumene; N , N -dimethylformamide (DMF), N , N -Dimethylacetamide (DMAC), N -Methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), gamma-butyrolactone (GBL), acetonitrile, N , N Examples of polar solvents include '-dimethylpropyleneurea (DMPU), hexamethylphosphoric triamide (HMPA), dichloromethane, chloroform, and the like. From the viewpoint of reactivity, however, preferred are hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, 4-methyltetrahydropyran; and acetonitrile; and more preferred are tetrahydrofuran, 2-methyltetrahydrofuran, toluene, and xylene. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mole of the 1,5-dihalopentane compound (6) from the viewpoint of reactivity.

[0028] The coupling reaction may be carried out in the presence of a catalyst, if necessary. Examples of the catalyst include copper compounds such as monovalent copper halides, such as cuprous chloride, cuprous bromide, and cuprous iodide, and divalent copper halides, such as cupric chloride, cupric bromide, and cupric iodide. From the viewpoint of reactivity, the monovalent copper halides are preferred, and cuprous iodide is more preferred. The catalyst may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available catalysts may be used. The amount of the catalyst used is preferably 0.0003 to 0.3 mol, more preferably 0.001 to 0.1 mol, per mol of the 1,5-dihalopentane compound (6), from the viewpoint of reaction rate and / or post-treatment.

[0029] When a catalyst is used in the coupling reaction, a cocatalyst may be used as necessary. Examples of the cocatalyst include trialkyl phosphite compounds having 3 to 9 carbon atoms, such as triethyl phosphite; triarylphosphine compounds having 18 to 21 carbon atoms, such as triphenylphosphine and tritolylphosphine; and arylphosphine compounds having 22 to 44 carbon atoms, such as 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP). From the viewpoint of reactivity, however, trialkyl phosphite compounds are preferred. The co-catalyst may be used alone or, if necessary, in combination of two or more kinds. In addition, commercially available co-catalysts may be used. The amount of the cocatalyst used is preferably 0.001 to 0.500 mol, more preferably 0.005 to 0.200 mol, per 1 mol of the 1,5-dihalopentane compound (6) from the viewpoint of reactivity.

[0030] When a catalyst is used in the coupling reaction, a lithium halide may be added as necessary. Examples of the lithium halide include lithium chloride, lithium bromide, and lithium iodide, and lithium chloride is preferred from the viewpoint of reactivity. The amount of lithium halide used in the coupling reaction is preferably 0.005 to 0.250 mol per 1 mol of the 1,5-dihalopentane compound (6) from the viewpoint of reactivity.

[0031] The reaction temperature in the coupling reaction varies depending on the 2-methyloctadecyl nucleophilic reagent (5) used, but is preferably −78 to 70° C., more preferably −20 to 50° C., and even more preferably 5 to 35° C., from the viewpoint of reactivity. The reaction time in the coupling reaction varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0032] X in the above general formula (6) 3 and X 4 When X are different from each other, the coupling reaction can be carried out while preferentially reacting the more reactive halogen atom by appropriately selecting the above catalyst or reaction temperature. 3 and X 4 When a 1,5-dihalopentane compound (6) in which the combination of X is a chlorine atom and a bromine atom or a chlorine atom and an iodine atom is used, the X in the 1-halo-7-methyltricosane compound (1) can be 1 can be a chlorine atom. 3 and X 4 If a 1,5-dihalopentane compound (6) is used, in which the combination of X is a bromine atom and an iodine atom, then the X in the 1-halo-7-methyltricosane compound (1) can be obtained. 1 can be a bromine atom.

[0033] In this step of the coupling reaction for producing the 1-halo-7-methyltricosane compound (1), 17,20-dimethylhexatriacontane having 38 carbon atoms is by-produced as an impurity. However, a sufficient boiling point difference can be ensured between the impurity and the target compound, the 1-halo-7-methyltricosane compound (1) having 24 carbon atoms. Therefore, the target compound can be easily separated and purified from the impurities by distillation purification, and as a result, a high-purity 1-halo-7-methyltricosane compound (1) can be produced.

[0034] The melting point of the haloalkane compound increases with an increase in the number of carbon atoms; for example, 1-chlorohexadecane has a melting point of 8 to 14°C, 1-chlorooctadecane has a melting point of 20°C, 1-chloroeicosane has a melting point of 37°C, and 1-chlorodocosane has a melting point of 41°C. Therefore, at room temperature of 20 to 25°C, 1-chlorohexadecane having a carbon number of 16 or less can be used as a liquid without the need for heating or dissolving in a solvent. On the other hand, among the above 1-halo-7-methyltricosane compounds (1), 1-chloro-7-methyltricosane (1:X), which has a carbon number of 24, 1 Contrary to expectations, 17-methylalkane (1:X =Cl) was in a liquid state even at 15°C. This is thought to be because, unlike linear haloalkanes, the presence of methyl branches at a suitable position lowers the melting point and allows the compound to remain in a liquid state. In addition, initially, a synthesis method via 1-chloro-2-methyleicosane was considered as an intermediate for synthesizing 17-methylalkane compounds, but 1-chloro-7-methyltricosane (1:X =Cl) was also found to be in a liquid state. 1 Although it has the same methyl branch as 1-chloro-7-methyltricosane (1:X =Cl), and the number of carbon atoms is 21, it is 1 =Cl), it was a solid at 15° C. Thus, the introduction of methyl branches at appropriate positions in the above 1-halo-7-methyltricosane compound (1) has succeeded in significantly lowering its melting point, and it can be used as a liquid at room temperature, making it possible to easily use it as an intermediate for the production of 17-methylalkane compounds.

[0035] (vi) Next, a method for producing the above 2-methyloctadecyl nucleophilic reagent (5) will be described below. The 2-methyloctadecyl nucleophile (5) can be prepared by conventional methods or according to the methods described below.

[0036] As the 2-methyloctadecyl nucleophilic reagent (5), for example, 2-methyloctadecyl magnesium halide reagent (5:M 2 =MgZ 2 ;Z 2 The production method in the case where R is the above-mentioned halogen atom will be described below. 2-Methyloctadecylmagnesium halide reagent (5:M 2 =MgZ 2 ;Z 2 is the above halogen atom) is a Grignard reagent.

[0037] 2-Methyloctadecylmagnesium halide reagent (5:M 2 =MgZ 2 ;Z 2 is the above halogen atom) can be prepared, for example, by reacting a 1-halo-2-methyloctadecane compound represented by the following general formula (9) with magnesium in a solvent, as shown in the following chemical reaction formula.

[0038] [ka]

[0039] (vii) First, the above 1-halo-2-methyloctadecane compound (9) will be explained below. X in the above general formula (9) 7 represents a halogen atom. Halogen atom X 7 Specific examples of the halogen atom include a chlorine atom, a bromine atom, and an iodine atom. Specific examples of the 1-halo-2-methyloctadecane compound (9) include 1-chloro-2-methyloctadecane, 1-bromo-2-methyloctadecane, and 1-iodo-2-methyloctadecane.

[0040] The 1-halo-2-methyloctadecane compound (9) may be used alone or in combination with two or more compounds as required. The 1-halo-2-methyloctadecane compound (9) may be a commercially available compound or may be independently synthesized.

[0041] The amount of magnesium used is preferably 1.0 to 2.0 gram atoms per mole of the 1-halo-2-methyloctadecane compound (9) from the viewpoint of completing the reaction. Examples of the solvent include general solvents, for example, ether-based solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; and hydrocarbon-based solvents such as hexane, heptane, benzene, toluene, xylene, and cumene. From the viewpoint of the reaction rate of the production of the Grignard reagent, preferred are hydrocarbon-based solvents such as toluene and xylene; and ether-based solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran, with tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran being more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mole of the 1-halo-2-methyloctadecane compound (9) from the viewpoint of reactivity.

[0042] The reaction temperature in the reaction with magnesium varies depending on the solvent used, but is preferably 30 to 120° C. from the viewpoint of reactivity. The reaction time in the reaction with magnesium varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0043] (viii) Next, a method for producing the above 1-halo-2-methyloctadecane compound (9) will be described below. The 1-halo-2-methyloctadecane compound (9) can be prepared according to conventional methods or according to the methods described below.

[0044] For example, the 1-halo-2-methyloctadecane compound (9) can be prepared by a coupling reaction between a pentadecyl nucleophile represented by the following general formula (7) and a 1,3-dihalo-2-methylpropane compound represented by the following general formula (8), as shown in the following chemical reaction formula.

[0045] [ka]

[0046] (ix) The above pentadecyl nucleophile (7) is explained below. M in the above general formula (7) 3 Li, MgZ 3 , CuZ 3 Or CuLiZ 3 represents Z 3 represents a halogen atom or a pentadecyl group. 3 Specific examples of the atom include a chlorine atom, a bromine atom, and an iodine atom, with a bromine atom and a chlorine atom being particularly preferred.

[0047] Specific examples of the pentadecyl nucleophilic reagent (7) include pentadecyllithium; pentadecylmagnesium halide reagents (Grignard reagents) such as pentadecylmagnesium chloride, pentadecylmagnesium bromide, and pentadecylmagnesium iodide; bis[pentadecyl]cuprate; and Gilman reagents such as lithium bis[pentadecyl]cuprate. From the viewpoint of ease of preparation (versatility), pentadecylmagnesium halide reagents are preferred. The pentadecyl nucleophile (7) may be used alone or in combination with two or more other compounds as required. The pentadecyl nucleophile (7) may be commercially available or may be prepared, for example, by the production method described below.

[0048] (x) Next, the above 1,3-dihalo-2-methylpropane compound (8) will be explained below. X in the above general formula (8) 5 and X 6 represent halogen atoms which may be the same or different. 5 and X 6 Specific examples of the halogen atom include a chlorine atom, a bromine atom, and an iodine atom. X 5 and X 6 Examples of the combinations include a chlorine atom and a chlorine atom, a bromine atom and a chlorine atom, a chlorine atom and an iodine atom, a bromine atom and a bromine atom, a bromine atom and an iodine atom, and an iodine atom and an iodine atom. Specific examples of the 1,3-dihalo-2-methylpropane compound (8) include 1,3-dichloro-2-methylpropane, 1,3-dibromo-2-methylpropane, 1,3-diiodo-2-methylpropane, 1-bromo-3-chloro-2-methylpropane, 1-chloro-3-iodo-2-methylpropane, and 1-bromo-3-iodo-2-methylpropane. From the viewpoint of yield, 1-bromo-3-chloro-2-methylpropane, 1-chloro-3-iodo-2-methylpropane, and 1-bromo-3-iodo-2-methylpropane are particularly preferred. The 1,3-dihalo-2-methylpropane compound (8) may be used alone or in combination with two or more compounds as required. The 1,3-dihalo-2-methylpropane compound (8) may be a commercially available compound or may be independently synthesized.

[0049] The 1,3-dihalo-2-methylpropane compound (8) can be synthesized, for example, by halogenating 2-methyl-1,3-propanediol.

[0050] (xi) Next, the coupling reaction of the pentadecyl nucleophile (7) with the 1,3-dihalo-2-methylpropane compound (8) will be described below. In the coupling reaction, the amount of the pentadecyl nucleophile (7) used is preferably 0.8 to 1.4 moles per mole of the 1,3-dihalo-2-methylpropane compound (8) from the viewpoint of economic efficiency.

[0051] The coupling reaction may be carried out in the presence of a solvent, if necessary. Examples of the solvent include common solvents, such as ether solvents, such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbon solvents, such as hexane, heptane, benzene, toluene, xylene, and cumene; N , N -dimethylformamide (DMF), N , N -Dimethylacetamide (DMAC), N -methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), gamma-butyrolactone (GBL), acetonitrile, N , N Examples of polar solvents include '-dimethylpropyleneurea (DMPU), hexamethylphosphoric triamide (HMPA), dichloromethane, chloroform, and the like. From the viewpoint of reactivity, however, preferred are hydrocarbon solvents such as toluene and xylene, ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, 4-methyltetrahydropyran, and the like, and acetonitrile, and more preferred are tetrahydrofuran, 2-methyltetrahydrofuran, toluene, and xylene. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mole of the 1,3-dihalo-2-methylpropane compound (8) from the viewpoint of reactivity.

[0052] The coupling reaction may be carried out in the presence of a catalyst, if necessary. Examples of the catalyst include copper compounds such as monovalent copper halides, such as cuprous chloride, cuprous bromide, and cuprous iodide, and divalent copper halides, such as cupric chloride, cupric bromide, and cupric iodide. From the viewpoint of reactivity, the monovalent copper halides are preferred, and cuprous iodide is more preferred. The catalyst may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available catalysts may be used. The amount of the catalyst used is preferably 0.0003 to 0.3 mol, more preferably 0.001 to 0.1 mol, per mol of the 1,3-dihalo-2-methylpropane compound (8) from the viewpoint of reaction rate and / or post-treatment.

[0053] When a catalyst is used in the coupling reaction, a cocatalyst may be used as necessary. Examples of the cocatalyst include phosphorus compounds such as trialkyl phosphite compounds having 3 to 9 carbon atoms, such as triethyl phosphite, triaryl phosphine compounds having 18 to 21 carbon atoms, such as triphenylphosphine and tritolylphosphine, and aryl phosphine compounds having 22 to 44 carbon atoms, such as 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), among which trialkyl phosphite compounds are preferred from the viewpoint of reactivity. The co-catalyst may be one type or, if necessary, two or more types. In addition, the co-catalyst may be a commercially available product. The amount of the cocatalyst used is preferably 0.001 to 0.500 mol, more preferably 0.005 to 0.200 mol, per 1 mol of the 1,3-dihalo-2-methylpropane compound (8) from the viewpoint of reactivity.

[0054] When a catalyst is used in the coupling reaction, a lithium halide may be added as necessary. Examples of the lithium halide include lithium chloride, lithium bromide, and lithium iodide, and lithium chloride is preferred from the viewpoint of reactivity. The amount of lithium halide used in the coupling reaction is preferably 0.005 to 0.250 mol per 1 mol of the 1,3-dihalo-2-methylpropane compound (8) from the viewpoint of reactivity.

[0055] The reaction temperature in the coupling reaction varies depending on the pentadecyl nucleophile (7) used, but is preferably −78 to 70° C., more preferably −20 to 50° C., and even more preferably 5 to 35° C., from the viewpoint of reactivity. The reaction time in the coupling reaction varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0056] X in the above general formula (8) 5 and X 6 When X are different from each other, the coupling reaction can be carried out while preferentially reacting the more reactive halogen atom by appropriately selecting the above catalyst or reaction temperature. 5 and X 6 When a 1,3-dihalo-2-methylpropane compound (8) in which the combination of X is a chlorine atom and a bromine atom or a chlorine atom and an iodine atom is used, the X in the 1-halo-2-methyloctadecane compound (9) can be obtained. 7 can be a chlorine atom. 5 and X 6 If a 1,3-dihalo-2-methylpropane compound (8) is used, in which the combination of X is a bromine atom and an iodine atom, then the X in the 1-halo-2-methyloctadecane compound (9) can be obtained. 7 can be a bromine atom.

[0057] In this step of the coupling reaction for producing the 1-halo-2-methyloctadecane compound (9), triacontane having 30 carbon atoms is by-produced as an impurity. However, a sufficient boiling point difference can be ensured between the impurity and the target compound, the 1-halo-2-methyloctadecane compound (9) having 19 carbon atoms. Therefore, the target compound can be easily separated and purified from the impurities by distillation purification, and as a result, a high-purity 1-halo-2-methyloctadecane compound (9) can be produced.

[0058] As described above, the melting point of a haloalkane compound increases with an increase in the number of carbon atoms, and for example, up to 1-chlorohexadecane having 16 carbon atoms can be used as a liquid at room temperature of 20 to 25° C. without the need for heating or dissolution in a solvent. Meanwhile, 1-chloro-2-methyleicosane having 21 carbon atoms, which was separately synthesized, was a solid at 15° C., but the 1-halo-2-methyloctadecane compound (9), which also has a methyl branch, and 1-chloro-2-methyloctadecane, were in a liquid state even at 15° C.

[0059] (xii) Next, a method for producing the above pentadecyl nucleophile (7) will be described below. The pentadecyl nucleophile (7) can be prepared by conventional methods or according to the methods described below.

[0060] For example, the pentadecyl nucleophile (7) is pentadecylmagnesium halide reagent (7:M 3 =MgZ 3 , Z 3 The production method for the case where the halogen atom is used is described below. 3 =MgZ 3 ) is a Grignard reagent.

[0061] Pentadecylmagnesium halide reagent (7:M 3 =MgZ 3 ) can be prepared, for example, by reacting a 1-halopentadecane compound represented by the following general formula (10) with magnesium in a solvent, as shown in the following chemical reaction formula.

[0062] [ka]

[0063] First, the 1-halopentadecane compound (10) will be described below. X in the above general formula (10) 8 represents a halogen atom. Halogen atom X 8 Specific examples of the halogen atom include a chlorine atom, a bromine atom, and an iodine atom. Specific examples of the 1-halopentadecane compound (10) include 1-chloropentadecane, 1-bromopentadecane, and 1-iodopentadecane.

[0064] The 1-halopentadecane compound (10) may be used alone or in combination with two or more compounds as necessary. The 1-halopentadecane compound (10) may be a commercially available compound or may be independently synthesized.

[0065] The amount of magnesium used is preferably 1.0 to 2.0 gram atoms per mole of the 1-halopentadecane compound (10) from the viewpoint of completing the reaction. Examples of the solvent include general solvents, for example, ether-based solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; and hydrocarbon-based solvents such as hexane, heptane, benzene, toluene, xylene, and cumene. From the viewpoint of the reaction rate of the production of the Grignard reagent, preferred are hydrocarbon-based solvents such as toluene and xylene; and ether-based solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran, with tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran being more preferred. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mole of the 1-halopentadecane compound (10) from the viewpoint of reactivity.

[0066] The reaction temperature in the reaction with magnesium varies depending on the solvent used, but is preferably 30 to 120° C. from the viewpoint of reactivity. The reaction time in the reaction with magnesium varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0067] <ii>Regarding the method for producing the 17-methylalkane compound represented by the following general formula (4), One of the target compounds of the present invention, a 17-methylalkane compound represented by the following general formula (4), can be prepared according to the production method shown in the following chemical reaction scheme. [ka]

[0068] (i) First, the above 7-methyltricosyl nucleophile (2) will be explained below. M in the above general formula (2) 1 Li, MgZ 1 , CuZ 1 Or CuLiZ 1 represents Z 1 represents a halogen atom or a 7-methyltricosyl group. 1 Specific examples of the atom include a chlorine atom, a bromine atom, and an iodine atom. 7-Methyltricosylmagnesium halide reagent (2:M 1 =MgZ 1 ) is a Grignard reagent.

[0069] Specific examples of the 7-methyltricosyl nucleophilic reagent (2) include 7-methyltricosyl lithium; 7-methyltricosylmagnesium halide reagents (Grignard reagents) such as 7-methyltricosylmagnesium chloride, 7-methyltricosylmagnesium bromide, and 7-methyltricosylmagnesium iodide; bis[7-methyltricosyl]cuprate; and Gilman reagents such as lithium bis[7-methyltricosyl]cuprate. From the viewpoint of ease of preparation (versatility), 7-methyltricosylmagnesium halide reagents are preferred.

[0070] (ii) A method for producing the above 7-methyltricosyl nucleophile (2) is described below. The production method includes at least a step of obtaining a 7-methyltricosyl nucleophile (2) using the above-mentioned 1-halo-7-methyltricosane compound (1).

[0071] As the 7-methyltricosyl nucleophilic reagent (2), for example, 7-methyltricosyl magnesium halide reagent (2:M 1 =MgZ 1 , Z 1 The production method in the case where R is the above-mentioned halogen atom will be described below. 7-Methyltricosylmagnesium halide reagent (2:M 1 =MgZ 1 , Z 1 is the above halogen atom) can be prepared, for example, by reacting the above 1-halo-7-methyltricosane compound (1) with magnesium in a solvent, as shown in the following chemical reaction formula.

[0072] [ka]

[0073] The 1-halo-7-methyltricosane compound (1) may be used alone or in combination of two or more, if necessary.

[0074] The amount of magnesium used is preferably 1.0 to 2.0 gram atoms per mole of the 1-halo-7-methyltricosane compound (1) from the viewpoint of completing the reaction. Examples of the solvent include general solvents, for example, ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; and hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene, and cumene. From the viewpoint of the reaction rate of the production of the Grignard reagent, preferred are hydrocarbon solvents such as toluene and xylene; and ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran, and more preferred are tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mole of the 1-halo-7-methyltricosane compound (1) from the viewpoint of reactivity.

[0075] The reaction temperature in the reaction with magnesium varies depending on the solvent used, but is preferably 30 to 120° C. from the viewpoint of reactivity. The reaction time in the reaction with magnesium varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0076] (iii) Next, a method for producing a 17-methylalkane compound (4) using the above 7-methyltricosyl nucleophilic reagent (2) will be described. The production method includes at least a step of obtaining a 17-methylalkane compound (4) by a coupling reaction between the above-mentioned 7-methyltricosyl nucleophile (2) and an alkyl electrophile represented by the following general formula (3).

[0077] [ka] The 7-methyltricosyl nucleophilic reagent (2) may be used alone or in combination with two or more other reagents as required. The 7-methyltricosyl nucleophilic reagent (2) may be a commercially available product or may be independently synthesized.

[0078] (iv) Next, the above alkyl electrophile (3) will be explained below. X in the above general formula (3) 2 is a halogen atom or p -Toluenesulfonyloxy group (CH3-C6H6-SO2-O (TsO) group). Halogen atom X 2 Specific examples of the halogen atom include a chlorine atom, a bromine atom, and an iodine atom, with a bromine atom and an iodine atom being particularly preferred. In the above general formula (3), n represents 11 to 13. Specific examples of alkyl electrophiles (3) include 1-halododecane compounds (n=11) such as 1-chlorododecane, 1-bromododecane, and 1-iodododecane; dodecyl= p -Toluenesulfonates (n=11); 1-halotridecane compounds such as 1-chlorotridecane, 1-bromotridecane and 1-iodotridecane (n=12); tridecyl = p -toluenesulfonates (n=12); and 1-halotetradecane compounds (n=13), such as 1-chlorotetradecane, 1-bromotetradecane, and 1-iodotetradecane; tetradecyl= p -toluenesulfonate (n=13), and from the viewpoint of ease of preparation (versatility), 1-halododecane compound (n=11), 1-halotridecane compound (n=12) and 1-halotetradecane compound (n=13) are preferred. When n is 11, the 17-methylalkane compound (4) produced by the coupling reaction between the above 7-methyltricosyl nucleophile (2) and the alkyl electrophile (3:n=11) having n=11 is 17-methylpentatriacontane (4:n=11), which is one of the target compounds of the present invention. When n is 13, the 17-methylalkane compound (4) produced by the coupling reaction between the above 7-methyltricosyl nucleophile (2) and the alkyl electrophile (3:n=13) having n=13 is 17-methylheptatriacontane (4:n=13), which is one of the target compounds of the present invention. The alkyl electrophile (3) may be used alone or in combination with two or more other types as required, and may be either commercially available or independently synthesized.

[0079] Alkyl electrophiles (3) can be prepared, for example, by halogenating 1-alkanols or by reacting 1-alkanols in the presence of a base. p It can be synthesized by tosylation with -toluenesulfonyl chloride.

[0080] (v) Next, the coupling reaction of 7-methyltricosyl nucleophile (2) with alkyl electrophile (3) is described below. X 2 but p The alkyl electrophile (3), which is the -toluenesulfonyloxy group, is 2 Similarly, alkyl electrophiles (3), in which 1 is a halogen atom, can be used in the above coupling reactions. p This is because the -toluenesulfonyloxy group serves as a good leaving group, similar to a halogen atom such as a bromine atom (see, for example, page 2127 of the above-mentioned Non-Patent Document 4, "Table 1" and the related descriptions).

[0081] In the coupling reaction, the amount of the 7-methyltricosyl nucleophile (2) used is preferably 0.8 to 1.2 moles per mole of the alkyl electrophile (3) from the viewpoint of economy.

[0082] The coupling reaction may be carried out in the presence of a solvent, if necessary. Examples of the solvent include common solvents, such as ether solvents, such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, dibutyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether, and 1,4-dioxane; hydrocarbon solvents, such as hexane, heptane, benzene, toluene, xylene, and cumene; N , N -dimethylformamide (DMF), N , N -Dimethylacetamide (DMAC), N -Methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), gamma-butyrolactone (GBL), acetonitrile, N , N Examples of polar solvents include '-dimethylpropyleneurea (DMPU), hexamethylphosphoric triamide (HMPA), dichloromethane, chloroform, and the like. From the viewpoint of reactivity, however, preferred are hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran, 4-methyltetrahydropyran; and acetonitrile; and more preferred are tetrahydrofuran, 2-methyltetrahydrofuran, toluene, and xylene. The solvent may be used alone or in combination with two or more solvents as required. In addition, commercially available solvents may be used. The amount of the solvent used is preferably 30 to 5,000 g, more preferably 50 to 3,000 g, per mole of the 7-methyltricosyl nucleophilic reagent (2) from the viewpoint of reactivity.

[0083] The coupling reaction may be carried out in the presence of a catalyst, if necessary. Examples of the catalyst include copper compounds such as monovalent copper halides, such as cuprous chloride, cuprous bromide, and cuprous iodide, and divalent copper halides, such as cupric chloride, cupric bromide, and cupric iodide. From the viewpoint of reactivity, monovalent copper halides are preferred, and cuprous chloride is more preferred. The catalyst may be used alone or in combination with two or more kinds, if necessary. In addition, commercially available catalysts may be used. The amount of the catalyst used is preferably 0.0003 to 0.300 mol, more preferably 0.001 to 0.100 mol, per mol of the 7-methyltricosyl nucleophilic reagent (2) from the viewpoint of reaction rate and / or post-treatment.

[0084] When a catalyst is used in the coupling reaction, a cocatalyst may be used as necessary. Examples of the cocatalyst include phosphorus compounds such as trialkyl phosphite compounds having 3 to 9 carbon atoms, such as triethyl phosphite, triaryl phosphine compounds having 18 to 21 carbon atoms, such as triphenylphosphine and tritolylphosphine, and aryl phosphine compounds having 22 to 44 carbon atoms, such as 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), among which trialkyl phosphite compounds are preferred from the viewpoint of reactivity. The co-catalyst may be used alone or, if necessary, in combination of two or more kinds. In addition, commercially available co-catalysts may be used. The amount of the cocatalyst used is preferably 0.001 to 0.500 mol, more preferably 0.005 to 0.200 mol, per mol of the 7-methyltricosyl nucleophilic reagent (2) from the viewpoint of reactivity.

[0085] When a catalyst is used in the coupling reaction, a lithium halide may be added as necessary. Examples of the lithium halide include lithium chloride, lithium bromide, and lithium iodide, and lithium chloride is preferred from the viewpoint of reactivity. The amount of lithium halide used in the coupling reaction is preferably 0.005 to 0.250 mol per 1 mol of the 7-methyltricosyl nucleophilic reagent (2) from the viewpoint of reactivity.

[0086] The reaction temperature in the coupling reaction varies depending on the 7-methyltricosyl nucleophilic reagent (2) used, but is preferably −78 to 70° C., more preferably −20 to 50° C., and even more preferably 5 to 35° C., from the viewpoint of reactivity. The reaction time in the coupling reaction varies depending on the solvent used and / or the reaction scale, but is preferably 0.5 to 100 hours from the viewpoint of reactivity.

[0087] (vi) Next, the above 17-methylalkane compound (4) will be explained below. In the above general formula (4), n is as defined in the above general formula (3). Specific examples of the 17-methylalkane compound (4) include 17-methylpentatriacontane (4: n=11), 17-methylhexatriacontane (4: n=12), and 17-methylheptatriacontane (4: n=13). In this step of the coupling reaction for producing 17-methylpentatriacontane (4:n=11), which is one of the target compounds of the present invention, tetracosane having 24 carbon atoms and 17,30-dimethylhexatetracontane having 48 carbon atoms are by-produced as impurities. However, the boiling point difference between the impurities and the target compound, 17-methylpentatriacontane (4:n=11) having 36 carbon atoms, can be sufficiently ensured. In addition, since the impurity, 17,30-dimethylhexatetracontane having 48 carbon atoms, has a very high melting point, it precipitates as a solid on the wall of the reactor during post-treatment of the coupling reaction and does not dissolve and mix into the organic layer, so it can be easily separated. Therefore, the target compound can be easily separated and purified from the impurities by distillation purification, column chromatography, recrystallization, or a combination of these, and as a result, high-purity 17-methylpentatriacontane (4:n=11) can be produced. Similarly, in the present step of the coupling reaction for producing 17-methylheptatriacontane (4:n=13), which is one of the target compounds of the present invention, octacosane having 28 carbon atoms and 17,30-dimethylhexatetracontane having 48 carbon atoms are by-produced as impurities. However, the boiling point difference between the impurities and the target compound, 17-methylheptatriacontane (4:n=13) having 38 carbon atoms, can be sufficiently ensured. In addition, since the impurity, 17,30-dimethylhexatetracontane having 48 carbon atoms, has a very high melting point, it precipitates as a solid on the wall of the reactor during post-treatment of the coupling reaction and does not dissolve and mix into the organic layer, so it can be easily separated. Therefore, the target compound can be easily separated and purified from the impurities by distillation purification, column chromatography, recrystallization, or a combination of these, and as a result, high-purity 17-methylheptatriacontane (4:n=13) can be produced.

[0088] In this manner, the 17-methylalkane compound (4), which is the nestmate recognition pheromone of the Argentine ant, can be produced from the synthetic intermediate 1-halo-7-methyltricosane compound (1) in a short process with high productivity and efficiency.

[0089] [Example] The present invention will be described in detail below with reference to examples, but the present invention is not limited to the following examples. In the following, unless otherwise specified, "purity" refers to the area percentage obtained by gas chromatography (GC) analysis, "production ratio" refers to the relative ratio of the area percentage obtained by GC analysis, and "yield" was calculated based on the area percentage obtained by GC analysis. In each example, reaction monitoring and yield calculation were performed according to the following GC conditions. GC conditions: GC: Shimadzu Corporation capillary gas chromatograph GC-2014, column: DB-5, 0.25 μm x 0.25 mm φ x 30 m, carrier gas: He (1.55 mL / min), detector: FID, column temperature: 150 °C, 5 °C / min heating up to 230 °C, UA-5, 0.25 μm x 0.25 mm φ x 10 m, carrier gas: He (1.55 mL / min), detector: FID, column temperature: 230 °C, 10 °C / min heating up to 300 °C.

[0090] The yield was calculated according to the following formula, taking into account the purity (%GC) of the raw materials and the product. Yield (%) = {[(weight of product obtained by reaction × %GC) / molecular weight of product] ÷[(weight of starting material in reaction × %GC) / molecular weight of starting material]} × 100 THF is tetrahydrofuran, and NMP is N -methyl-2-pyrrolidone and Et represents an ethyl group.

[0091] [Example 1] 1-Chloro-2-methyloctadecane (9:X 7 Production of 1-chloropentadecane, a raw material for (=Cl)

[0092] [ka]

[0093] Magnesium (160.74 g, 6.61 gram atoms) and tetrahydrofuran (1890.00 g) were added to a reactor at room temperature and stirred for 25 minutes at 60 to 65° C. Next, 1-chlorododecane (1290.12 g, 6.30 mol, purity 100%) was added dropwise to the reactor at 60 to 75° C. After the dropwise addition was completed, the mixture was stirred at 75 to 80° C. for 2 hours to prepare dodecyl magnesium chloride. Next, cuprous iodide (12.00 g, 0.063 mol), triethyl phosphite (25.12 g, 0.15 mol), tetrahydrofuran (630.00 g) and 1-bromo-3-chloropropane (922.44 g, 5.86 mol) were added to another reactor, and the dodecyl magnesium chloride prepared above was added dropwise at 5 to 15° C. After the dropwise addition was completed, the mixture was stirred at 10 to 20° C. for 1 hour. Next, an aqueous solution of ammonium chloride (ammonium chloride (63.00 g) and water (1735.66 g)), 20% by mass hydrochloric acid (63.00 g), and 25% by mass aqueous solution of sodium hydroxide (32.04 g) were added to the reaction solution, and the liquids were separated. The organic layer obtained was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain 1-chloropentadecane (1311.04 g, 5.26 mol, purity 99.08%, bp = 150.3 to 152.3 ° C. / 0.37 kPa (2.8 mmHg)) as a liquid in a yield of 89.81%. The obtained 1-chloropentadecane did not contain tetracosane, which is a homo-coupling product of dodecyl magnesium chloride (below the GC detection limit).

[0094] The spectral data of 1-chloropentadecane obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.88(3H,t,J=6.9Hz),1.21-1.34(22H,m),1.38-1.46(2H,m),1.77(2H,tt,J=6.9Hz,6.9Hz),3.53(2H,t,J=6.9Hz); 13 C-NMR (125MHz, CDCl3): δ=14.1,22.7,26.9,28.9,29.4,29.47,29.55,29.62,29.65,29.69,31.9,32.7,45.2 [Mass spectrum] EI-mass spectrum (70 eV): m / z 246 (M + ), 217, 203, 189, 175, 161, 147, 133, 119, 105, 71, 57, 43, 29 [Infrared absorption spectrum] (D-ATR): ν=2955, 2924, 2854, 1466, 1377, 1308, 723, 655

[0095] [Example 2] 1-Chloro-2-methyloctadecane (9:X 7 Preparation of (=Cl)

[0096] [ka]

[0097] Magnesium (120.90 g, 4.98 gram atoms) and tetrahydrofuran (1421.40 g) were added to a reactor at room temperature and stirred at 60 to 65° C. for 37 minutes. Next, 1-chloropentadecane (1180.48 g, 4.74 moles, purity 99.08%) produced in Example 1 was added dropwise to the reactor at 60 to 75° C. After completion of the dropwise addition, the mixture was stirred at 75 to 80° C. for 2 hours to obtain pentadecyl magnesium chloride (7:M 3 = MgCl) was prepared. Then, in a separate reactor, cuprous iodide (CuI) (9.02 g, 0.047 mol), triethyl phosphite (P(OEt)3) (18.90 g, 0.11 mol), tetrahydrofuran (947.60 g), and 1-bromo-3-chloro-2-methylpropane (8:X 5 =Br,X 6 =Cl) (755.52 g, 4.41 mol, purity 100%) was added to the reaction mixture, and the pentadecyl magnesium chloride prepared above was added dropwise at 10 to 20°C. After the dropwise addition was completed, the mixture was stirred at 10 to 20°C for 1.5 hours. Next, an aqueous solution of ammonium chloride (ammonium chloride (47.38 g) and water (1305.32 g)), 20% by mass hydrochloric acid (90.72 g), and 25% by mass aqueous solution of sodium hydroxide (45.36 g) were added to the reaction mixture, and the mixture was separated. The organic layer obtained was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain 1-chloro-2-methyloctadecane (9:X 7 The resulting 1-chloro-2-methyloctadecane (9:X = Cl) (1190.20 g, 3.89 mol, purity 98.92%, bp = 161.1-167.0 °C / 0.044 kPa (0.33 mmHg)) was obtained as a liquid in a yield of 88.20%. 7 =Cl) did not contain triacontane, which is a homo-coupling product of pentadecylmagnesium chloride (below the GC detection limit).

[0098] The 1-chloro-2-methyloctadecane (9:X 7 The spectral data for (=Cl) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.88(3H,t,J=6.9Hz),1.00(3H,d,J=6.9Hz),1.20-1.50(30H ,m),1.76-1.84(1H,m),3.48(1H,dd,J=10.5Hz,5.4Hz),3.40(1H,dd,J=10.5Hz,6.5Hz); 13 C-NMR (125MHz, CDCl3): δ=14.11,17.77,22.69,26.84,29.37,29.59,29.63,29.66,29.70,29.75,31.93,33.97,35.52,51.28 [Mass spectrum] EI-mass spectrum (70 eV): m / z 302 (M + ), 253, 197, 188, 169, 153, 141, 127, 113, 105, 99, 85, 71, 57, 41 [Infrared absorption spectrum] (D-ATR): ν=2924, 2853, 1465, 1378, 722, 688

[0099] [Example 3] 1-Chloro-7-methyltricosane (1:X 1 Preparation of (=Cl)

[0100] [ka]

[0101] At room temperature, magnesium (59.35 g, 2.44 gram atoms) and tetrahydrofuran (930.40 g) were added to the reactor and stirred at 60-65° C. for 35 minutes. Next, 1-chloro-2-methyloctadecane (9:X) prepared in Example 2 was added to the reactor. 7 2-Methyloctadecylmagnesium chloride (5:M =Cl) (712.40 g, 2.33 mol, purity 98.92%) was added dropwise at 60 to 75 °C. After completion of the dropwise addition, the mixture was stirred at 75 to 80 °C for 2 hours to obtain 2-methyloctadecylmagnesium chloride (5:M =Cl). 2 = MgCl) was prepared. Then, in a separate reactor, cuprous iodide (4.43 g, 0.023 mol), triethyl phosphite (9.28 g, 0.056 mol), tetrahydrofuran (465.20 g), and 1-bromo-5-chloropentane (6:X 4 =Br,X 3 =Cl) (409.88 g, 2.21 mol, purity 100%) was added, and the pentadecyl magnesium chloride prepared above was added dropwise at 15 to 25°C. After completion of the dropwise addition, the mixture was stirred at 20 to 30°C for 1.5 hours. Next, an aqueous solution of ammonium chloride (ammonium chloride (23.26 g) and water (640.81 g)), 20% by mass hydrochloric acid (22.27 g), and 25% by mass aqueous solution of sodium hydroxide (11.83 g) were added to the reaction liquid and the liquids were separated. The organic layer obtained was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain 1-chloro-7-methyltricosane (1:X 1 =Cl) (708.34 g, 1.85 mol, purity 97.18%, bp = 183.1-196.2 °C / 0.044 kPa (0.33 mmHg)) was obtained as a liquid with a yield of 83.50%. 1 =Cl) is 2-methyloctadecylmagnesium chloride (5:M 2 = MgCl), was not contained (below the GC detection limit).

[0102] The 1-chloro-7-methyltricosane (1:X 1 The spectral data for (=Cl) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.84(3H,d,J=6.5Hz),0.88(3H,t,J=6.9Hz),1.04-1.12(2H,m),1 .20-1.33(35H,m),1.38-1.47(2H,m),1.77(2H,tt,J=6.9Hz,6.9Hz),3.53(2H,t,J=6.9Hz); 13 C-NMR(125MHz,CDCl3):δ=14.11,19.68,22.70,26.90,26.93,27.09,29.25, 29.37,29.66,29.71,29.74,30.02,31.93,32.68,32.71,36.95,37.06,45.17 [Mass spectrum] EI-mass spectrum (70 eV): m / z 357 (M + -14), 253, 224, 197, 169, 147, 111, 99, 85, 71, 57, 43, 29 [Infrared absorption spectrum] (D-ATR): ν=2924, 2853, 1465, 1377, 1304, 723, 656

[0103] [Example 4] Preparation of 17-methylpentatriacontane (4:n=11)

[0104] [ka]

[0105] Magnesium (3.31 g, 0.14 gram atom) and tetrahydrofuran (86.5 g) were added to the reactor at room temperature and stirred at 60-65° C. for 28 minutes. Next, 1-chloro-7-methyltricosane (1:X) prepared in Example 3 was added to the reactor. 1 7-Methyltricosylmagnesium chloride (2:M =Cl) (49.87 g, 0.13 mol, purity 97.18%) was added dropwise at 60 to 75°C. After completion of the dropwise addition, the mixture was stirred at 75 to 80°C for 3.5 hours to obtain 7-methyltricosylmagnesium chloride (2:M =Cl). 1 = MgCl) was prepared. Then, in a separate reactor, cuprous chloride (0.15 g, 0.0015 mol), triethyl phosphite (1.46 g, 0.0088 mol), lithium chloride (0.10 g, 0.0024 mol), tetrahydrofuran (100.00 g), and 1-bromododecane (3:X 2 =Br, n=11) (32.38 g, 0.13 mol), and the above-prepared 7-methyltricosylmagnesium chloride (2:M 1 =MgCl) was added dropwise. After the completion of the dropwise addition, the mixture was stirred at 20 to 30°C for 2.5 hours. Next, an aqueous solution of acetic acid (acetic acid (1.30 g) and water (35.79 g)), 20 mass% hydrochloric acid (2.72 g), and 25 mass% aqueous solution of sodium hydroxide (2.72 g) were added to the reaction liquid and separated, and the obtained organic layer was directly distilled under reduced pressure to separate tetracosane, and the residue was purified by silica gel column chromatography (hexane:ethyl acetate = 100:0) to obtain 17-methylpentatriacontane (4:n = 11) (56.51 g, 0.10 mol, purity 93.48%) as a solid in a yield of 80.23%. The obtained 17-methylpentatriacontane (4:n = 11) was mixed with 7-methyltricosylmagnesium chloride (2:M 1 No 17,30-dimethylhexatetracontane, a homo-coupling product of 1,2-dimethylphenylsulfonyl ether (COOH) and 1,2-dimethylphenylsulfonyl ether (COOH) was contained (below the detection limit of GC). In this example, purification was performed by column chromatography, but since there were no impurities to be separated, purification by distillation and / or recrystallization is also possible.

[0106] The spectral data of 17-methylpentatriacontane (4:n=11) obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.84(3H,d,J=6.9Hz),0.88(6H,t-like,J=6.9Hz),1.18-1.33(65H,m); 13 C-NMR (125MHz, CDCl3): δ=14.13,19.73,22.67,22.71,27.11,29.38,29.68,29.73,29.76,30.05,31.95,32.76,37.11 [Mass spectrum] EI-mass spectrum (70 eV): m / z 492 (M + -14), 280, 252, 224, 197, 183, 169, 155, 141, 127, 113, 99, 85, 71, 57, 43, 29 [Infrared absorption spectrum] (D-ATR): ν=2956, 2917, 2850, 1470, 1377, 720

[0107] [Example 5] Preparation of 17-methylheptatriacontane (4:n=13)

[0108] [ka]

[0109] Magnesium (3.31 g, 0.14 gram atom) and tetrahydrofuran (86.5 g) were added to the reactor at room temperature and stirred at 60-65° C. for 19 minutes. Next, 1-chloro-7-methyltricosane (1:X) prepared in Example 3 was added to the reactor. 1 7-Methyltricosylmagnesium chloride (2:M =Cl) (49.87 g, 0.13 mol, purity 97.18%) was added dropwise at 60 to 75 °C. After completion of the dropwise addition, the mixture was stirred at 75 to 80 °C for 5 hours to obtain 7-methyltricosylmagnesium chloride (2:M =Cl). 1 = MgCl) was prepared. Then, in a separate reactor, cuprous chloride (0.15 g, 0.0015 mol), triethyl phosphite (1.46 g, 0.0088 mol), lithium chloride (0.10 g, 0.0024 mol), tetrahydrofuran (100.00 g), and 1-bromotetradecane (3:X 2 =Br, n=13) (36.02 g, 0.13 mol), and the above-prepared 7-methyltricosylmagnesium chloride (2:M 1 =MgCl) was added dropwise. After the completion of the dropwise addition, the mixture was stirred at 20 to 30°C for 2 hours. Next, an aqueous solution of acetic acid (acetic acid (1.30 g) and water (35.79 g)), 20 mass% hydrochloric acid (2.72 g), and 25 mass% aqueous solution of sodium hydroxide (2.72 g) were added to the reaction solution to separate the liquids, and the obtained organic layer was directly distilled under reduced pressure to separate octacosane. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 100:0) to obtain 17-methylheptatriacontane (4:n = 13) (54.82 g, 0.094 mol, purity 91.51%) as a solid in a yield of 72.18%. The obtained 17-methylheptatriacontane (4:n = 13) was mixed with 7-methyltricosylmagnesium chloride (2:M 1 No 17,30-dimethylhexatetracontane, a homo-coupling product of 17,30-dimethylhexatetracontane (COOH = MgCl), was contained (below the GC detection limit). In this example, purification was performed by column chromatography, but since there were no impurities to be separated, purification by distillation or recrystallization is also possible.

[0110] The spectral data of 17-methylheptatriacontane (4:n=13) obtained above is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.84(3H,d,J=6.5Hz),0.88(6H,t,J=6.9Hz),1.03-1.12(2H,m),1.20-1.33(67H,m); 13 C-NMR (125MHz, CDCl3): δ=14.12,19.73,22.71,27.10,29.38,29.68,29.72,29.75,30.05,31.94,32.75,37.11 [Mass spectrum] EI-mass spectrum (70 eV): m / z 519 (M + -1), 463, 393, 351, 308, 252, 183, 169, 155, 141, 71, 57 [Infrared absorption spectrum] (D-ATR): ν=2958, 2918, 2850, 1473, 1464, 1377, 729, 719

[0111] [Example 6] 1-Bromo-7-methyltricosane (1:X 1 =Br)

[0112] [ka]

[0113] At room temperature, the reactor was charged with 1-chloro-7-methyltricosane (1:X 1 =Cl) (10.00 g, 0.26 mol, purity 97.18%), 1-bromopropane (CH3CH2CH2Br) (19.02 g, 0.15 mol), sodium bromide (NaBr) (0.53 g, 0.0052 mol), N N-methyl-2-pyrrolidone (NMP) (19.00 g) was added and heated to 110-120°C. 1-Chloropropane produced during the reaction was distilled out of the reaction system, and after confirming a reaction rate of >99% by GC, the system was cooled to 25°C. Next, water (35.16 g) and hexane (10.31 g) were added to the reaction liquid to separate the liquid. The organic layer obtained was concentrated, and the residue was purified by silica gel column chromatography (hexane:ethyl acetate = 50:1) to obtain 1-bromo-7-methyltricosane (1:X). 1 =Br) (10.93 g, 0.26 mol, 100% purity) was obtained as a liquid in 100% yield.

[0114] The 1-bromo-7-methyltricosane (1:X 1 The spectral data for Br) is shown below. [Nuclear Magnetic Resonance Spectrum] 1 H-NMR (500MHz, CDCl3): δ=0.84(3H,d,J=6.5Hz),0.88(3H,t,J=6.9Hz),1.03-1.14(2H,m),1 .18-1.36(35H,m),1.39-1.47(2H,m),1.86(2H,tt,J=6.9Hz,6.9Hz),3.41(2H,t,J=6.9Hz); 13 C-NMR(125MHz,CDCl3):δ=14.11,19.68,22.70,26.87,27.09,28.23,29.13, 29.37,29.66,29.71,29.74,30.02,31.93,32.71,32.86,34.02,36.94,37.06 [Mass spectrum] EI-mass spectrum (70 eV): m / z 403 (M + -13), 337, 253, 191, 169, 155, 127, 111, 99, 85, 71, 57, 43, 29 [Infrared absorption spectrum] (D-ATR): ν=2923, 2853, 1465, 1377, 1259, 722, 648, 566< / ii>

Claims

1. The following general formula (1): 【Chemistry 1】 (In the formula, X 1 represents a halogen atom.) The 1-halo-7-methyltricosane compound represented by the formula:

2. The following general formula (1): 【Chemistry 2】 (In the formula, X 1 represents a halogen atom.) The 1-halo-7-methyltricosane compound (1) represented by the following general formula (2): 【Chemistry 3】 (In the formula, M 1 Li, MgZ 1 , CuZ 1 Or CuLiZ 1 represents Z 1 represents a halogen atom or a 7-methyltricosyl group. Then, the 7-methyltricosyl nucleophile (2) is converted into a 7-methyltricosyl nucleophile represented by the following general formula (3): 【Chemistry 4】 (In the formula, X 2 represents a halogen atom or a p-toluenesulfonyloxy group, and n represents 11 to 13. By a coupling reaction with an alkyl electrophilic reagent represented by the following general formula (4): 【Chemistry 5】 (In the formula, n is as defined above.) A step of obtaining a 17-methylalkane compound represented by the formula: The method for producing the 17-methylalkane compound (4) comprises at least the steps of:

3. The following general formula (5): 【Chemistry 6】 (In the formula, M 2 Li, MgZ 2 , CuZ 2 Or CuLiZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. and a 2-methyloctadecyl nucleophile represented by the following general formula (6): 【Chemistry 7】 (In the formula, X 3 and X 4 represent halogen atoms which may be the same or different. A step of obtaining the 1-halo-7-methyltricosane compound (1) by a coupling reaction with a 1,5-dihalopentane compound represented by the following formula: The method for producing the 17-methylalkane compound (4) according to claim 2, further comprising:

4. The following general formula (7): 【Chemistry 8】 (In the formula, M 3 Li, MgZ 3 , CuZ 3 Or CuLiZ 3 represents Z 3 represents a halogen atom or a pentadecyl group. and a pentadecyl nucleophile represented by the following general formula (8): 【Chemistry 9】 (In the formula, X 5 and X 6 represent halogen atoms which may be the same or different. By a coupling reaction with a 1,3-dihalo-2-methylpropane compound represented by the following formula (9): 【Chemistry 10】 (In the formula, X 7 represents a halogen atom.) obtaining a 1-halo-2-methyloctadecane compound represented by the formula: preparing the 2-methyloctadecyl nucleophile (5) from the 1-halo-2-methyloctadecane compound (9); The method for producing the 17-methylalkane compound (4) according to claim 3, further comprising:

5. The following general formula (5): 【Chemistry 11】 (In the formula, M 2 Li, MgZ 2 , CuZ 2 Or CuLiZ 2 represents Z 2 represents a halogen atom or a 2-methyloctadecyl group. and a 2-methyloctadecyl nucleophile represented by the following general formula (6): 【Chemistry 12】 (In the formula, X 3 and X 4 represent halogen atoms which may be the same or different. By a coupling reaction with a 1,5-dihalopentane compound represented by the following general formula (1): 【Chemistry 13】 (In the formula, X 1 represents a halogen atom.) A step of obtaining a 1-halo-7-methyltricosane compound (1) represented by the following formula: The method for producing the 1-halo-7-methyltricosane compound (1) comprises the steps of:

6. The following general formula (7): 【Chemistry 14】 (In the formula, M 3 Li, MgZ 3 , CuZ 3 Or CuLiZ 3 represents Z 3 represents a halogen atom or a pentadecyl group. and a pentadecyl nucleophile represented by the following general formula (8): 【Chemistry 15】 (In the formula, X 5 and X 6 represent halogen atoms which may be the same or different. By a coupling reaction with a 1,3-dihalo-2-methylpropane compound represented by the following formula (9): 【Chemistry 16】 (In the formula, X 7 represents a halogen atom.) obtaining a 1-halo-2-methyloctadecane compound represented by the formula: preparing the 2-methyloctadecyl nucleophile (5) from the 1-halo-2-methyloctadecane compound (9); The method for producing the 1-halo-7-methyltricosane compound (1) according to claim 5, further comprising:

Citation Information

Patent Citations

  • Preparation of triacontyl halide

    JP1984001432A

  • 10-halo-5,9-dimethyldecane and manufacturing method of 5,9-dimethylalkane using the same

    JP2007084447A